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Highly enantioselective hydrogenation and transfer
hydrogenation of cycloalkyl and heterocyclic ketones
catalysed by an iridium complex of a tridentate
phosphine-diamine ligand†
Jose´ A. Fuentes,a Ian Carpenter,a Nina Kannb and Matthew L. Clarke*a
Ir complexes of chiral phosphine-diamine ligands catalyse the hydro-
genation and transfer hydrogenation of aryl-piperidin-4-ylmethanones,
and ketones bearing both an aryl group and secondary alkyl substituent
with up to 98% e.e., and with substrate to catalyst ratios of up to 4000.
The enantioselective reduction of ketones using molecular hydro-
genation is one of the most important and scalable methods for
preparing the ubiquitous chiral building blocks, secondary alcohols.
The excellent results that are obtained in the reduction of a wide
range of acetophenone derivatives using Noyori catalysts of type
[RuCl2(diphos)(diamine)] are well known, and these Ru complexes
are industrially viable catalysts (Fig. 1, 1).1 Most of these catalysts
give between 85–99% e.e. and high rates for acetophenone deriva-
tives. There has been considerable interest in examining both
fundamentally different and slightly modified catalyst structures
for ketone hydrogenation.2–5 This line of enquiry should, in principle
lead to increased substrate scope. A case in point is the development
of a range of Ru complexes of phosphine diamine and phosphine
amino-alcohol ligands (Fig. 1, 2).3 These catalysts proved quite
effective for the hydrogenation of a-tertiary alkyl ketones,3a hetero-
cycle functionalised bulky ketones,3b,c esters3d,e and cyano-ketones.3f
Unfortunately, we have only been partially successful in ration-
ally tuning the ligand structure to increase the ‘sweetspot’ in
substrate scope for asymmetric hydrogenations.3g Using the Ru
catalysts, we were unable to get synthetically useful results for some
of our target applications, including the enantioselective hydro-
genation of aryl(piperidin-4-yl)methanones. This was of interest to
us, in part due to the steric bulk and free secondary amine
presenting challenges, but more importantly due to their repeated
occurrence as a chiral building block in the pharmaceutical patent
literature.6 Motivated by the renaissance in the hydrogenation of
carbonyl derivatives using iridium complexes,5 we have studied Ir
catalysed ketone hydrogenation using phosphine-diamine ligands
derived from cyclohexane-diamine. Here we show that changing
from ruthenium to iridium, with the same very economic ligand
system, delivers a catalyst that is able to hydrogenate this class of
ketone to give the industrially important enantioenriched alcohols
with high enantioselectivity. We also report an initial investigation
into substrate scope that reveals this catalyst is highly competent
for the reduction of a range of other substrates.
Due to the tendency of ligand 3 to give mixtures on reaction
with well-known Ir precursors, and the observation that the
best selectivity was observed with a ligand:iridium ratio of 0.5,
an equimolar combination of [IrCl(COD)]2/(R,R)-3 was used as
pre-catalyst in most of the reactions discussed below.
We examined the hydrogenation of the unprotected aryl(piper-
idin-4-yl)methanones 5k to 8k; these were readily prepared from
the Weinreb amides of the piperidines.† While Rh catalysts have
been used on chelating unprotected amino-ketones,4d hydrogena-
tion of secondary amine-containing ketones generally requires
protecting groups;1b,g,h the very few studies that specifically
mention aryl(piperidin-4-yl)methanones use protected or tertiary
amines.1h,7 We were therefore delighted to find that good conver-
sions and high enantioselectivity can be obtained using this iridium
catalyst. The dimethoxyphenyl substituted secondary alcohol has
been the subject of large scale asymmetric synthesis studies
before, from the Boc protected ketone 6k; 18 kilos of DIP-chloride
chiral reducing agent were required to produce 6.45 Kg of product
Fig. 1 Schematic of the Noyori catalysts and the systems studied in St Andrews.
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with 72.9% e.e. (4.6 Kg of 93% e.e. product after recryst.).6a Using
either the Boc protected or the free NH compound and these new
unoptimised catalytic protocols delivers product with higher selectivity
with significantly better atom economy. The Boc protected ketone
seems to reduce somewhat faster, but with lower selectivity in the
hydrogenations (Table 1, entries 2 and 4). Aryl(piperidin-4-yl)metha-
nones with less bulky aryl groups gave yet higher selectivity (Table 1,
entries 6–10), reaching close to enantiopurity (Scheme 1).
In order to investigate if this high selectivity was a very specific
niche for piperidine functionalised ketones, a range of studies were
carried out on ketones 9k–12k. The results in Table 2 show that
using 0.1% of the new Ir system, the cyclohexyl substituted ketone,
9k can be reduced very selectively: 98% e.e. and high conversion are
obtained in 20 minutes at room temperature (Table 2, entry 5).
While we have not carried out a full scale up study, we note that,
even using amagnetically stirred reaction vessel, high conversion for
the hydrogenation of 9k can be reached using 0.025 mol% catalyst
loading with 95% e.e.; a single unoptimised recrystallisation gave
enantiopure material in 61% yield. Isobutyrophenone, 10k was also
reduced with high enantioselectivity (Table 2, entry 10). The tertiary
alkyl substituted ketones gave significantly inferior results than
those obtained with Ru catalysts of ligand 3. However, rather more
encouraging results could be obtained when ligand 3 is substituted
with P-chiral ligand 4. For example, the successful and completely
chemoselective hydrogenation of the unsaturated ketone 12k at
0.1 mol% catalyst loading with significantly better e.e. than
with the parent system (Table 2: compare entries 13 and 14)
shows that this type of catalyst can be tuned and therefore
bodes well for other applications.
All our attempts at reacting ligand 3 with [IrCl(COD)]2 or
[Ir(COD)2]
+ at various stoichiometries gave mixtures that could
not be characterised and also decomposed within hours, even in
degassed solvents. Many attempts at growing crystals suitable for
X-ray diﬀraction failed. A complex that was free of any obvious
impurities could be isolated from the reaction of [Ir(OMe)(COD)]2
and ligand 3. The spectroscopic data is quite strongly supportive
of an amido complex with a formula [Ir(L–H)(COD)] (13) in
which ligand 3 exhibits a tridentate anionic coordination
mode. Further discussion of this assignment is in the ESI.†
With this complex and the in situ system in hand, we have
carried our preliminary studies to understand the nature of this
reduction, which is carried out in IPA solvent. Complex 13 and
[IrCl(COD)]2/3 also catalyse transfer hydrogenation using IPA as
hydrogen source. These reactions give similarly high selectivity
and productivity as the hydrogenations, and isolated complex
13 behaves similarly to the in situ catalyst (Scheme 2 and
further examples in ESI,† Table S3).
The hydrogenation reactions do utilise molecular hydrogen
as reductant as confirmed by an experiment using a ballast vessel at
constant pressure, and enhanced conversion at room temperature
relative to transfer hydrogenation.† The stoichiometric reaction
of 13 with hydrogen in the absence of IPA gives cyclooctane
Table 1 Hydrogenation of piperidine functionalised substrates 5k–8ka
Entry Substrate T (1C) Time (h) Conversion (%) [ yield] ee
1 5k 35 71 70 80b
2 5k 50 25 499 [68] 78
3 6k 17 48 499 [94] 75
4 6k 50 17 499 75
5 6k 50 17 499 69c
6 7k 35 71 499 [71] 94
7 7k 15 65 75 93
8 8k 22 42 499 [77] 96
9 8k 50 14 499 [72] 93
10 8k 50 2 499 96
a Reactions carried out using 0.1 mol% [IrCl(COD)]2 and 0.1% (R,R)-3
using 2 mol% KOtBu co-catalyst in dry IPA at 50 bar initial hydrogen
pressure, unless indicated otherwise. See ESI for determination of ee
and configurations. b (R,R)-3 gives S product. c 0.05 mol% [IrCl(COD)]2
0.1% 3.
Scheme 1 Substrates (k) reduced to alcohols (al) in this study.
Table 2 Hydrogenation of substrates 9k–12ka
Entry Substrate
Catalyst (%)




(%) [ yield] ee
1 9k 0.05 [0.1] 50 17 499 77(S)
2 9k 0.1 [0.1] 50 17 499 [89] 84(S)
3 9k 0.05 [0.05] 80 2 89 90(S)
4b 9k 0.025 [0.025] 60 46 89 95(S)
5 9k 0.1 [0.1] 21 0.33 78 98(S)
6c 9k 0.1 21 0.33 85 97(S)
7 9k 0.1 [0.1] 45 1 98 93(S)
8c 9k 0.1 45 1 97 87(S)
9c 9k 0.1 50 3 98.5 64(S)
10 10k 0.5 [0.5] 50 1 499 [97] 89(S)
11 11k 0.05 [0.1] 50 22 99 18.5(S)
12 11kd 0.05 [0.1] 50 22 98 [89] 67(S)
13 12k 0.1 [0.1] 17 48 96 32
14 12kd 0.05 [0.1] 40 22 99 [80] 71
a Reactions carried out using 0.1 mol% [IrCl(COD)]2 and 0.1% ligand
(R,R)-3 using 2 mol% KOtBu co-catalyst in dry IPA at 50 bar initial
hydrogen pressure, unless indicated otherwise. See ESI for determina-
tion of ee and configurations. b 0.025% [IrCl(COD)]2, 0.25% KO
tBu,
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(from hydrogenation of COD), and several Ir-hydride species as
determined by the multitude of peaks in the hydride region of the
1H NMR. The amido complex also reduces ketones very slowly
but selectively without added base.† The gas uptake of two
complex-13-catalysed reductions of 9k at 24 and 10 bar show
that the reactions are zero order in substrate and positive order in
hydrogen.† This was confirmed for both 13 and the in situ catalyst
with separate experiments run at 0.25 and 0.5 M concentration at
50 bar pressure. The independence on substrate concentration,
implying that hydride transfer is faster than other steps in the
cycle (i.e. activation of hydrogen), is in contrast to the slower
reactions catalysed by Ru complexes of P, NH, NH2 ligands.
3c This
shows that the Ir systems are more proficient at the transfer of
hydride to the ketone. Complex 13 gives significantly lower
selectivity than [IrCl(COD)]2/3 under pressure hydrogenation
reactions at higher temperatures (e.g. 64% e.e. 99% conv. after
3 hours at 50 1C, 0.1% 13), but gives similar results at room
temperature (e.g. 96% e.e. at 81% conv. after 20 minutes at 21 1C,
0.1% 13). For the [IrCl(COD)]2/3 system the e.e. does not degrade
too much from 98% maximum right up to 80 1C (Table 2). A full
table (20 expts) is provided in the ESI.† A hydrogenation carried
out in d8-IPA reveals that over 90% of the CD(OH/D) signal is
deuterated and hence the transfer hydrogenation is competitive
with pressure hydrogenation. While since it is possible that Ir
catalysed H–D exchange can occur, but this is only possible
when the fundamental steps of transfer hydrogenation are
competitive with those of pressure hydrogenation. In the Ru
catalysed reductions, less than 20% of deuterium incorporation
is observed3a in accordance with those catalysts being much
slower at transfer hydrogenation.
In conclusion, the combination of [IrCl(COD)]2 and chiral P,
N, N ligands derived from cyclohexane diamine gives a catalyst
that exhibits high selectivity and activity in the hydrogenation
and transfer hydrogenation of ketones bearing an aryl substitu-
ent and some form of secondary alkyl group. The selectivity and
activity observed is significantly higher than that obtained with a
Ru catalyst derived from the same ligand (or in fact the use of
[RhCl(COD)]2/ligand 3.†). The ability to deliver490% e.e. at low
catalyst loading and near ambient temperature for these more
challenging substrates means this catalyst is already of synthetic
use, but this type of iridium catalyst is also a worthwhile lead
structure for further research.
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